About Parenteral Drugs (India) Ltd
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products.
Founded
1983
CEO
Manoharlal Gupta
Employees
909
HQ
Indore, India
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
About Parenteral Drugs (India) Ltd
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products.
Founded:1983
CEO:Manoharlal Gupta
Employees:909
HQ:Indore, India
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹3
52W Low
₹0
Volume1.06K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-0.13x
Valuation
P/B Ratio
N/A
Valuation
EPS
₹-25.61
Valuation
Dividend Yield
0.00%
Valuation
ROE
15.60%
Profitability
ROCE
7.69%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
-0.13x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-27.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.